|
Inhibition of Ehrlich ascites carcinoma growth by melatonin: Studies with micro-CT
|
16 February 2024 |
|
Intra-tumor ROS amplification by melatonin interferes in the apoptosis-autophagy-inflammation-EMT collusion in the breast tumor microenvironment
|
16 February 2024 |
|
Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer
|
11 February 2024 |
|
Melatonin and carcinogenesis in mice: the 50th anniversary of relationships
|
19 January 2024 |
|
Potential of melatonin to reverse epigenetic aberrations in oral cancer: new findings
|
18 January 2024 |
|
Melatonin, circadian rhythms and breast cancer
|
18 January 2024 |
|
Melatonin: A Powerful Integrative Adjunctive Agent for Oncology
|
07 January 2024 |
|
Prevalence and clinical outcomes of vitamin D deficiency among Japanese multiple myeloma patients: a single-center observational study
|
07 January 2024 |
|
Somatostatin Inhibited the EMT of Pancreatic Cancer Cells by Mediating the TGF-β/Smad Signaling Pathway
|
06 January 2024 |
|
Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses
|
06 January 2024 |